Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02746471 · ClinicalTrials.gov registry record
Reveal LINQ Registry
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 1,604
- Enrollment target
NCT02746471 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,604 participants.
The verdict
NCT02746471 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 1,604 participants
- Enrollment target
Study Summary
The Reveal LINQ Registry will generate reliable long-term "real world" data of product performance, economic valuation, site-of-service procedural information.
Interventions
- DEVICE Reveal LINQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,604 participants |
| Start Date | 2014-04 |
| Est. Completion | 2021-06-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02746471
The ClinicalTrials.gov registry entry for NCT02746471 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,604 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reveal LINQ is the first listed.
NCT02746471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02746471 about?
NCT02746471 is a clinical study titled "Reveal LINQ Registry". The Reveal LINQ Registry will generate reliable long-term "real world" data of product performance, economic valuation, site-of-service procedural information.
What is the current status of trial NCT02746471?
This trial is currently completed. The enrollment target is 1,604 participants. The study started on 2014-04. Estimated completion is 2021-06-04.
What interventions are being tested in trial NCT02746471?
The interventions under investigation include: Reveal LINQ (DEVICE).
Who is sponsoring clinical trial NCT02746471?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.